GMAB institutional ownership changes in Q2 2026: 66 institutions opened or added positions, 55 trimmed or exited. GMAB (Genmab A/S) is held by 119 institutional investors as of Q2 2026. Top institutional shareholders: Orbis Allan Gray Ltd ($312.3M), AllianceBernstein L.P. ($231.9M), Arrowstreet Capital, Limited Partnership ($136.7M). Institutions were buying, on balance.
Who's Trading
Source dates: Price Nov 6, 2026 · Insiders none · Activists none · Congress none
No recent insider, activist, or congressional trades for GMAB.
Top Holders
| Action | ||||||
|---|---|---|---|---|---|---|
Decreased | 11.4M(-12.1%) | $312.3M | 1.1% | +118.29% | 0 | |
Decreased | 8.6M(-9.6%) | $231.9M | 0.1% | +66.89% | 0 | |
Unchanged | 5M | $136.7M | 0.1% | +136.33% | 0 | |
Increased | 4.7M(+3.0%) | $128.3M | 0.0% | +110.31% | 31 | |
Decreased | 3.5M(-20.3%) | $96.6M | 0.1% | +95.46% | 0 | |
Increased | 3.5M(+49.9%) | $96.3M | 0.1% | +112.87% | 41 | |
Decreased | 3.1M(-4.5%) | $86.9M | 0.8% | +79.82% | 0 | |
Increased | 2.8M(+12.0%) | $75.7M | 0.0% | +98.47% | 33 | |
New | 2.5M | $68M | 0.0% | +102.11% | 41 | |
Increased | 1.7M(+149.4%) | $46.4M | 0.0% | +103.32% | 47 | |
Decreased | 1.6M(-25.4%) | $44.8M | 0.0% | +128.44% | 0 | |
Increased | 1.4M(+15.8%) | $39.8M | 0.1% | +93.18% | 34 | |
Increased | 1.3M(+37.4%) | $35.1M | 0.0% | +92.89% | 38 | |
Increased | 1.2M(+0.8%) | $33M | 0.0% | +104.92% | 29 | |
Decreased | 1.1M(-1.1%) | $29.3M | 0.0% | -10.81% | 0 | |
Increased | 961,053(+222.4%) | $26.4M | 0.0% | +103.86% | 46 | |
Decreased | 916,600(-3.6%) | $25.2M | 0.0% | +99.59% | 0 | |
Increased | 910,604(+14.9%) | $25M | 0.0% | +106.43% | 33 | |
Increased | 883,430(+10.8%) | $24.3M | 0.0% | +157.45% | 32 | |
Decreased | 829,687(-3.8%) | $22.8M | 0.0% | +66.55% | 0 |
Showing 1-20 of 125
GMABGenmab A/SContinue exploring
Other Healthcare stocks held by institutions
UNHUnitedHealth Group Incorporated
LLYEli Lilly and Company
TMOThermo Fisher Scientific Inc
JNJJohnson & Johnson
DHRDanaher Corporation
ISRGIntuitive Surgical, Inc.
MRKMerck & Company, Inc.
ABBVAbbVie Inc.
BSXBoston Scientific Corporation
ABTAbbott LaboratoriesQuestions investors ask about GMAB
Who owns GMAB?
119 institutional investors held GMAB on June 30, 2026, led by Orbis Allan Gray Ltd ($312.3M), AllianceBernstein L.P. ($231.9M) and Arrowstreet Capital, Limited Partnership ($136.7M).
How many hedge funds hold GMAB?
119 institutional investors reported GMAB in their 13F filings for the quarter ended June 30, 2026, $1.9B in all. 8 of them are rated Elite.
Are institutions buying or selling GMAB?
Buying, on balance. In Q2 2026, 66 institutions opened or added to positions in GMAB and 55 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer